The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergy of TLR4 agonist GSK1795091, an innate immune activator, with agonistic antibody against co-stimulatory immune checkpoint molecule OX40 in cancer immunotherapy.
 
Hua-Xin Gao
Employment - GlaxoSmithKline
 
Sabyasachi Bhattacharya
Employment - GlaxoSmithKline
 
Christopher Jon Matheny
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Niranjan Yanamandra
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Shu-Yun Zhang
Employment - GlaxoSmithKline
 
Heidi Emerich
Employment - GlaxoSmithKline
 
Yufeng Li
Employment - GlaxoSmithKline
 
Paul Bojczuk
Employment - GlaxoSmithKline
 
Hong Shi
Employment - GlaxoSmithKline
 
Wei Wang
Employment - GlaxoSmithKline
 
Christopher Hopson
Employment - GlaxoSmithKline
 
Tihui Fu
No Relationships to Disclose
 
James Patrick Allison
Patents, Royalties, Other Intellectual Property - Inventor of a patent held by the University of California, Berkeley, and licensed to Bristol Meyers-Squibb; Inventor of a patent owned by Memorial Sloan-Kettering Cancer Center and licensed by Jounce Therapeutics
 
Padmanee Sharma
Stock and Other Ownership Interests - BioAtla; Constellation Pharmaceuticals; Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics; Neon Therapeutics (I); Oncolytics
Consulting or Advisory Role - Amgen; Amgen (I); Astellas Pharma; AstraZeneca; AstraZeneca (I); BioAtla; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Constellation Pharmaceuticals; Constellation Pharmaceuticals (I); EMD Serono; EMD Serono (I); Evelo Therapeutics; Evelo Therapeutics (I); GlaxoSmithKline; GlaxoSmithKline (I); Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Merck Sharp & Dohme; Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Pieris Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)
 
James F . Smothers
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; GlaxoSmithKline
 
Roopa Srinivasan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Axel Hoos
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline